National colorectal cancer (CRC) screening
guidelines have
recommended offering patients
choice for more than 5 years1-3

The U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS) recommend the following considerations to improve screening rates and to help reduce CRC-related deaths1-3:

Experts from the USPSTF and the ACS agree that including patients in the decision-making process may help improve adherence1-3


Offering choice in screening options resulted in greater adherence than offering colonoscopy alone4

In one study, adherence rates nearly doubled when patients were offered a noninvasive approach or given a choice of 2 screening options over colonoscopy alone4*

Adherence to CRC screening

Study design: In a randomized study of racially and ethnically diverse adults aged 50 to 79 years at average risk for CRC (N=997), healthcare providers presented patients with CRC screening recommendations by one of the following methods4:

  • Fecal occult blood test (FOBT) (n=344)
  • Colonoscopy (n=332)
  • Choice of FOBT or colonoscopy (n=321)